Influence on regulatory decisions for drugs with limited evidence

BMJ 2026

View at publisher
Authors: Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Timothée Olivier
DOI: 10.1136/bmj-2026-137466
Cited by: 2
References: 8

Abstract

Conflicts of interest and political and emotional pressures are key challenges

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Biomedical Ethics and Regulation Statistical Methods in Clinical Trials

Publication details

Journal / source
BMJ
Publisher
BMJ
Volume
393
Pages
e137466–e137466
Publication date
10 June 2026
Language
EN